[Current trends in prevention and therapy of postmenopausal osteoporosis].
Rossi
G
G
D000818:Animals; D004965:Estrogen Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D004967:Estrogens / Q000819:agonists*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control* / Q000628:therapy; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use*; D020849:Raloxifene Hydrochloride; D051381:Rats; D013997:Time Factors
D004965:Estrogen Antagonists; D004967:Estrogens; D010880:Piperidines; D020849:Raloxifene Hydrochloride
Attuali prospettive nella prevenzione e nella terapia dell'osteoporosi postmenopausa.